- +107.2% price growth over the last year
- Low bankruptcy risk (Altman Z-Score: 5.93)
- Bullish trend confirmed on both short and long timeframes
Beam Therapeutics Inc. stock price ended at $34.81 on Friday, after gaining 2.59%
(Updated on Jun 26, 2026)
The Beam Therapeutics Inc. stock price gained 2.59% on the last trading day (Friday, 26th Jun 2026), rising from $33.93 to $34.81. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.96% from a day low at $33.30 to a day high of $35.95. The price has risen in 7 of the last 10 days and is up by 18.36% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $166.68 million.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $35.96 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 22.91% during the next 3 months and, with a 90% probability hold a price between $35.02 and $44.20 at the end of this 3-month period.
BEAM Signals & Forecast
The Beam Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $34.00 and $30.87. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 22, 2026, and so far it has fallen -2.03%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Beam Therapeutics Inc. stock
Beam Therapeutics Inc. finds support from accumulated volume at $33.20 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.65 between high and low, or 7.96%. For the last week, the stock has had daily average volatility of 8.01%.
Our recommended stop-loss: $33.33 (-4.25%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (BEAM) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect Beam Therapeutics Inc. to open at $34.69, and during the day (based on 14 day Average True Range), to move between $33.63 and $35.99, which gives a possible trading interval of +/-$2.35 (+/-6.99%) up or down from last closing price. If Beam Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 6.99% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $35.53 (2.07%) than the support at $33.20 (4.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Beam Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Beam Therapeutics Inc. stock to perform well in the short-term.
Current score:
3.767
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 29, 2026 - $34.69 ( 0.354%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BEAM Performance
Trading levels for BEAM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 37.34 | 7.26% |
| R2 | 36.32 | 4.35% |
| R1 | 35.70 | 2.55% |
| Price | 34.81 | |
| S1 | 33.67 | -3.26% |
| S2 | 33.05 | -5.06% |
| S3 | 32.04 | -7.97% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 35.53 | 2.07% |
| Price | 34.81 | |
| S1 | 33.20 | -4.63% |
| S2 | 32.84 | -5.66% |
| S3 | 27.11 | -22.12% |
BEAM Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jan 22, 2014 | Feb 04, 2014 | Mar 03, 2014 | $0.225 | 0% |
| 2 | Sep 19, 2013 | Nov 04, 2013 | Dec 02, 2013 | $0.225 | 0% |
| 3 | Jul 31, 2013 | Aug 12, 2013 | Sep 03, 2013 | $0.225 | 0% |
| 4 | Apr 24, 2013 | May 06, 2013 | Jun 03, 2013 | $0.225 | 0% |
| 5 | Jan 28, 2013 | Feb 04, 2013 | Mar 01, 2013 | $0.225 | 0% |
FAQ
Click here for our free guide on how to buy Beam Therapeutics Inc. Stock.
Buy BEAM